Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT03724747 · COMPLETED
Trial details
- NCT number
- NCT03724747
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2022-08-25
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.